Pyrazinamide
Pyrazinamide Tablets, USP 500 mg Rx Only
Approved
Approval ID
ab904db1-1fbc-40a3-ad92-ece998dc49e2
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 22, 2023
Manufacturers
FDA
A-S Medication Solutions
DUNS: 830016429
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Pyrazinamide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code50090-5963
Application NumberANDA080157
Product Classification
M
Marketing Category
C73584
G
Generic Name
Pyrazinamide
Product Specifications
Route of AdministrationORAL
Effective DateMay 12, 2021
FDA Product Classification
INGREDIENTS (4)
PYRAZINAMIDEActive
Quantity: 500 mg in 1 1
Code: 2KNI5N06TI
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT